[Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002825:Chorioretinitis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007933:Leucomycins / Q000008:administration & dosage*; D011739:Pyrimethamine / Q000008:administration & dosage*; D013411:Sulfadiazine / Q000008:administration & dosage*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy*; D014126:Toxoplasmosis, Ocular / Q000151:congenital / Q000188:drug therapy
D007933:Leucomycins; D013411:Sulfadiazine; D011739:Pyrimethamine
La toxoplasmose congénitale traitée. Résultats cliniques et biologiques.